Skip to content
healthcare.dev
Get a free key

RiaSTAP

NDC 63833-891, FIBRINOGEN HUMAN, injection, powder, lyophilized, for solution, from CSL Behring GmbH.

Product NDC
63833-891
Status
Listed
Labeler
CSL Behring GmbH
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
PLASMA DERIVATIVE
Marketing category
BLA
Application
BLA125317
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63833-891 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FIBRINOGEN HUMAN1300 mg/50mL

Pharmacologic classes

Blood Coagulation Factors [CS]; Human Blood Coagulation Factor [EPC]; Increased Coagulation Activity [PE]

Package NDCNDC-11Package
63833-891-51638330891511 VIAL, SINGLE-USE in 1 CARTON (63833-891-51) / 50 mL in 1 VIAL, SINGLE-USE (63833-891-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=63833-891

Use it

Look up 63833-891 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63833-891 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63833-891. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.